Oral health, dental treatment, and medication related osteonecrosis of the jaw in multiple myeloma – a longitudinal cohort study

被引：0
作者：
Richard Olofsson
Magdalena Korytowska
Ulrica Almhöjd
Annica Almståhl
Hülya Cevik-Aras
机构：
[1] Public Dental Service,Specialist Clinic for Orofacial Medicine Uddevalla
[2] Region Västra Götaland, Trollhättan
[3] Institute of Odontology,Department of Oral Microbiology and Immunology
[4] Sahlgrenska Academy,Specialist Clinic for Orofacial Medicine, Karlstad
[5] University of Gothenburg,Department of Oral Maxillofacial Surgery and Oral Medicine
[6] Public Dental Service,Department of Cariology, Institute of Odontology, Sahlgrenska Academy
[7] Malmö University,Section 4 – Oral health, Faculty of Odontology
[8] University of Gothenburg,Department of Oral Pathology and Medicine
[9] Malmö University,undefined
[10] Institute of Odontology,undefined
[11] Sahlgrenska Academy,undefined
[12] University of Gothenburg,undefined
来源：
BMC Oral Health | / 24卷
关键词：
Bisphosphonates; Dental surgery; Medication related osteonecrosis of the jaw; Multiple myeloma; Oral health; Oral health related quality of life;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 162 条
[1]  
Ludwig H(2020)Multiple myeloma incidence and mortality around the globe; interrelations between health access and quality, economic resources, and patient empowerment Oncologist 25 e1406-e1413
[2]  
Novis Durie S(2010)Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management Leukemia. 24 1121-1127
[3]  
Meckl A(2008)Pathogenesis and treatment of renal failure in multiple myeloma Leukemia. 22 1485-1493
[4]  
Hinke A(2014)International myeloma working group updated criteria for the diagnosis of multiple myeloma Lancet Oncol 15 e538-e548
[5]  
Durie B(2020)Multiple myeloma: the (r)evolution of current therapy and a glance into future Haematologica. 105 2358-2367
[6]  
Kyle RA(2022)American Association of Oral and Maxillofacial Surgeons’ position paper on medication-related osteonecrosis of the Jaws-2022 update J Oral Maxillofac Surg Off J Am Assoc Oral Maxillofac Surg 80 920-943
[7]  
Durie BGM(2019)The impact of the oral cavity in febrile neutropenia and infectious complications in patients treated with myelosuppressive chemotherapy Support Care Cancer Off J Multinatl Assoc Support Care Cancer 27 3667-3679
[8]  
Rajkumar SV(2018)The role of dental care providers in the management of patients prescribed bisphosphonates: brief clinical guidance Gen Dent 66 18-24
[9]  
Landgren O(2008)Dental treatment planning and management in the patient who has cancer Dent Clin N Am 52 19-37
[10]  
Blade J(1996)Bisphosphonates: a review of their pharmacokinetic properties Bone. 18 75-85
12345678910